TL;DR CAR-T cell therapy in India costs ₹30-50 lakhs compared to ₹3-4 crores abroad, making treatment 80% more affordable [1] India now has 2 approved CAR-T therapies: NexCAR19 and Qartemi, with 70-83% response rates in clinical trials [1] [6] Dr Bharat Patodiya (founder of Pi Cancer Care/ Pi Oncology) provides comprehensive CAR-T evaluation and patient selection protocols with specialized follow-up programs Major centers include Tata Memorial, AIIMS, Apollo, and SMS Hospital